Literature DB >> 19181096

Acute quadriplegic myopathy: an acquired "myosinopathy".

Lars Larsson1.   

Abstract

Acquired neuromuscular disorders have been shown to be very common in critically ill patients receiving prolonged mechanical ventilation in the intensive care unit (ICU). Acute Quadriplegic Myopathy (AQM) is a specific acquired myopathy in ICU patients. Patients with AQM are characterized by severe muscle weakness and atrophy of spinal nerve innervated limb and trunk muscles, while cranial nerve innervated craniofacial muscles, sensory and cognitive functions are spared or less affected. The muscle weakness is associated with altered muscle membrane properties and a preferential loss of the motor protein myosin and myosin-associated thick filament proteins. Prolonged mechanical ventilation, muscle unloading, postsynaptic block of neuromuscular transmission, sepsis and systemic corticosteroid hormone treatment have been suggested as important triggering factors in AQM. However, the exact mechanisms underlying the loss of thick filament proteins are not known, though enhanced myofibrillar protein degradation in combination with a downregulation of protein synthesis at the transcriptional level play important roles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19181096     DOI: 10.1007/978-0-387-84847-1_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Aspects of physical medicine and rehabilitation in the treatment of deconditioned patients in the acute care setting: the role of skeletal muscle.

Authors:  Michael Quittan
Journal:  Wien Med Wochenschr       Date:  2016-01-12

2.  Statistical insights into major human muscular diseases.

Authors:  Shakti Gupta; Sung-Min Kim; Yu Wang; Ashok Reddy Dinasarapu; Shankar Subramaniam
Journal:  Hum Mol Genet       Date:  2014-02-25       Impact factor: 6.150

3.  Sparing of muscle mass and function by passive loading in an experimental intensive care unit model.

Authors:  Guillaume Renaud; Monica Llano-Diez; Barbara Ravara; Luisa Gorza; Han-Zhong Feng; Jian-Ping Jin; Nicola Cacciani; Ann-Marie Gustafson; Julien Ochala; Rebeca Corpeno; Meishan Li; Yvette Hedström; G Charles Ford; K Sreekumaran Nair; Lars Larsson
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Authors:  Susan D Kraner; Qingbo Wang; Kevin R Novak; Dongmei Cheng; David R Cool; Junmin Peng; Mark M Rich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

Review 6.  Muscle wasting in disease: molecular mechanisms and promising therapies.

Authors:  Shenhav Cohen; James A Nathan; Alfred L Goldberg
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

7.  Clustering gene expression regulators: new approach to disease subtyping.

Authors:  Mikhail Pyatnitskiy; Ilya Mazo; Maria Shkrob; Elena Schwartz; Ekaterina Kotelnikova
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 8.  Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care.

Authors:  Silvia De Rosa; Sara Samoni; Claudio Ronco
Journal:  Crit Care       Date:  2016-03-15       Impact factor: 9.097

Review 9.  Myosinopathies: pathology and mechanisms.

Authors:  Homa Tajsharghi; Anders Oldfors
Journal:  Acta Neuropathol       Date:  2012-08-05       Impact factor: 17.088

10.  Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model.

Authors:  Hazem Akkad; Rebeca Corpeno; Lars Larsson
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.